Form 4: Envista CEO Paul Keel Boosts Equity Holdings

Sentiment:

Statement of Changes in Beneficial Ownership


Envista Holdings Corp CEO Paul A. Keel reported significant equity grants, including Restricted Stock Units, Performance Share Units, and stock options, aligning his interests with long-term shareholder value.

Summary

  • Paul A. Keel, Chief Executive Officer and Director of Envista Holdings Corp (NVST), reported transactions on February 25, 2026.
  • Disposed of 11,840 shares of common stock at a price of $29.59 per share to satisfy tax withholding obligations related to the vesting of stock-settled Restricted Stock Units.
  • Acquired 48,670 Restricted Stock Units (RSUs) which will vest ratably on each anniversary of the grant date over three years, subject to continued service. Each RSU converts to one share of common stock.
  • Acquired 132,885 Performance Share Units (PSUs) at target performance. These PSUs will vest based on the achievement of identified performance measures over a three-year period, with a potential payout ranging from 0% to 200% of the target amount.
  • Acquired 115,320 Employee Stock Options with an exercise price of $29.59. These options will vest ratably on each anniversary of the grant date over three years, subject to continued service, and have an expiration date of February 25, 2036.
  • Following these reported transactions, Keel directly beneficially owns 384,385 shares of common stock, 132,885 Performance Share Units, and 115,320 Employee Stock Options.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a moderately positive development, as it signifies a routine but substantial alignment of the CEO's financial incentives with the company's long-term performance and shareholder interests through significant equity grants.

Positives

  • The significant equity grants, including RSUs, PSUs, and stock options, align the CEO's long-term financial interests directly with those of Envista Holdings Corp's shareholders.
  • The Performance Share Units incentivize the CEO to achieve specific company performance measures over a three-year period, directly linking compensation to corporate success.
  • The multi-year vesting schedules for RSUs and stock options encourage continued service and long-term commitment from the CEO, promoting leadership stability.

Negatives

  • The disposition of 11,840 shares for tax withholding, while a routine event upon the vesting of previous awards, represents a reduction in direct share ownership at that specific point in time.

Risks

  • The actual number of shares ultimately received from the Performance Share Units is uncertain, as it is contingent upon achieving identified performance measures, with a potential payout ranging from 0% to 200% of the target amount.
  • The vesting of Restricted Stock Units and Employee Stock Options is subject to the CEO's continued service through each vesting date, meaning the awards could be forfeited if employment terminates prematurely.

Future Outlook

The equity grants, including Restricted Stock Units, Performance Share Units, and stock options, are structured with multi-year vesting periods (three years), indicating a long-term incentive strategy tied to the CEO's continued service and the company's future performance.

Industry Context

StockSavvy.ai notes that the granting of Restricted Stock Units, Performance Share Units, and stock options to executive officers like the CEO is a standard practice in publicly traded companies within the healthcare and dental industry, such as Dentsply Sirona Inc. (XRAY) or Align Technology, Inc. (ALGN), to align management incentives with long-term shareholder value and retention.

Comparison to Industry Standards

  • The use of a mix of time-based (RSUs, options) and performance-based (PSUs) equity awards is a common executive compensation strategy, similar to practices seen at peer companies like Zimmer Biomet Holdings (ZBH) or Stryker Corporation (SYK).
  • The three-year vesting period for RSUs and options, and the three-year performance period for PSUs, aligns with typical long-term incentive plans in the medical device and dental equipment sector.
  • The 0%-200% payout range for PSUs based on performance is a standard mechanism to link executive pay directly to company results, comparable to incentive structures at companies like Danaher Corporation (DHR), Envista's former parent company.

Stakeholder Impact

  • Shareholders: The equity grants align the CEO's financial incentives with the long-term creation of shareholder value.
  • Employees: May signal stability in leadership and a commitment to long-term strategic objectives within the company.

Next Steps

  • Continued service by the CEO for the vesting of Restricted Stock Units and Employee Stock Options over the next three years.
  • Achievement of identified performance measures over the next three years for the vesting of Performance Share Units.

Key Dates

DateDescription
02/25/2026Date of reported transactions for equity grants and tax withholding.
02/25/2036Expiration date for the newly acquired Employee Stock Options.

Keywords

Envista Holdings, NVST, Form 4, Paul Keel, CEO, Director, Equity Compensation, Restricted Stock Units, Performance Share Units, Stock Options, Insider Trading, Executive Compensation

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.